Literature DB >> 18085442

The predictive significance of autoantibodies in organ-specific autoimmune diseases.

Nicola Bizzaro1.   

Abstract

Many organ-specific autoimmune diseases are preceded by a long pre-clinical phase, and several longitudinal cohort studies have shown that patients may carry autoantibodies many years before they manifest clinical symptoms. Detecting these antibodies in serum has been shown to have strong predictive value, depending on the particular autoantibody, test method, and disease at issue. This review examines the predictive value of various autoantibodies that are found in organ-specific autoimmune diseases, such as primary biliary cirrhosis, Addison's disease, Hashimoto's thyroiditis, type-1 diabetes, celiac disease, and Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18085442     DOI: 10.1007/s12016-007-8059-5

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  29 in total

1.  Natural history of early primary biliary cirrhosis.

Authors:  J V Metcalf; H C Mitchison; J M Palmer; D E Jones; M F Bassendine; O F James
Journal:  Lancet       Date:  1996-11-23       Impact factor: 79.321

Review 2.  Epidemiological and ethical aspects of multiplex autoantibody testing.

Authors:  Ettore Bidoli; Danilo Villalta; M Battistin; E Bidoli; A Cammarota; M Ciccone; R Fedato; B Lodi; F Marchesini; G Molaro; E Ostardo; G Rellini; R Sartori; D Schinella
Journal:  Autoimmun Rev       Date:  2007-01-31       Impact factor: 9.754

Review 3.  The laboratory approach to the diagnosis of autoimmune diseases: is it time to change?

Authors:  Danilo Villalta; Renato Tozzoli; Elio Tonutti; Nicola Bizzaro
Journal:  Autoimmun Rev       Date:  2007-02-07       Impact factor: 9.754

4.  Natural history of preclinical IDDM in high risk siblings. Childhood Diabetes in Finland Study Group.

Authors:  M Knip; P Vähäsalo; J Karjalainen; R Lounamaa; H K Akerblom
Journal:  Diabetologia       Date:  1994-04       Impact factor: 10.122

5.  II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addison's disease.

Authors:  C Betterle; M Volpato; B Rees Smith; J Furmaniak; S Chen; R Zanchetta; N A Greggio; B Pedini; M Boscaro; F Presotto
Journal:  J Clin Endocrinol Metab       Date:  1997-03       Impact factor: 5.958

6.  I. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: markers of low progression to clinical Addison's disease.

Authors:  C Betterle; M Volpato; B Rees Smith; J Furmaniak; S Chen; N A Greggio; M Sanzari; F Tedesco; B Pedini; M Boscaro; F Presotto
Journal:  J Clin Endocrinol Metab       Date:  1997-03       Impact factor: 5.958

7.  Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies.

Authors:  C F Verge; R Gianani; E Kawasaki; L Yu; M Pietropaolo; R A Jackson; H P Chase; G S Eisenbarth
Journal:  Diabetes       Date:  1996-07       Impact factor: 9.461

8.  A prospective study of the incidence of childhood celiac disease.

Authors:  Edward J Hoffenberg; Todd MacKenzie; Katherine J Barriga; George S Eisenbarth; Fei Bao; Joel E Haas; Henry Erlich; T l Bugawan Tl; Ronald J Sokol; Iman Taki; Jill M Norris; Marian Rewers
Journal:  J Pediatr       Date:  2003-09       Impact factor: 4.406

9.  Prevalence of Celiac disease among children in Finland.

Authors:  Markku Mäki; Kirsi Mustalahti; Jorma Kokkonen; Petri Kulmala; Mila Haapalahti; Tuomo Karttunen; Jorma Ilonen; Kaija Laurila; Ingrid Dahlbom; Tony Hansson; Peter Höpfl; Mikael Knip
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

10.  Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfunction in subjects with preclinical Addison's disease.

Authors:  S Laureti; A De Bellis; V I Muccitelli; F Calcinaro; A Bizzarro; R Rossi; A Bellastella; F Santeusanio; A Falorni
Journal:  J Clin Endocrinol Metab       Date:  1998-10       Impact factor: 5.958

View more
  14 in total

Review 1.  Translational Mini-Review Series on B Cell-Directed Therapies: B cell-directed therapy for autoimmune diseases.

Authors:  C Hu; F S Wong; L Wen
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

Review 2.  Can rheumatoid arthritis be prevented?

Authors:  Kevin D Deane
Journal:  Best Pract Res Clin Rheumatol       Date:  2013-10-02       Impact factor: 4.098

3.  Thyroid autoimmunity may represent a predisposition for the development of fibromyalgia?

Authors:  L Bazzichi; A Rossi; C Zirafa; F Monzani; S Tognini; A Dardano; F Santini; M Tonacchera; M De Servi; C Giacomelli; F De Feo; M Doveri; G Massimetti; S Bombardieri
Journal:  Rheumatol Int       Date:  2010-11-18       Impact factor: 2.631

Review 4.  Preclinical rheumatoid arthritis: identification, evaluation, and future directions for investigation.

Authors:  Kevin D Deane; Jill M Norris; V Michael Holers
Journal:  Rheum Dis Clin North Am       Date:  2010-05       Impact factor: 2.670

Review 5.  Multiplex planar microarrays for disease prognosis, diagnosis and theranosis.

Authors:  Peter Lea
Journal:  World J Exp Med       Date:  2015-08-20

6.  Evaluation of anti-mutated citrullinated vimentin antibodies, anti-cyclic citrullinated Peptide antibodies and rheumatoid factor in omani patients with rheumatoid arthritis.

Authors:  Ahmed Al-Shukaili; Saif Al-Ghafri; Safia Al-Marhoobi; Juma Alkaabi
Journal:  Int J Rheumatol       Date:  2012-08-15

7.  Autoimmune thyroid disease in rheumatoid arthritis: a global perspective.

Authors:  Jorge Cárdenas Roldán; Jenny Amaya-Amaya; Juan Castellanos-de la Hoz; Juliana Giraldo-Villamil; Gladys Montoya-Ortiz; Paola Cruz-Tapias; Adriana Rojas-Villarraga; Rubén D Mantilla; Juan-Manuel Anaya
Journal:  Arthritis       Date:  2012-11-18

8.  Design of targeted B cell killing agents.

Authors:  Alexey V Stepanov; Alexey A Belogurov; Natalia A Ponomarenko; Oleg A Stremovskiy; Leonid V Kozlov; Anna M Bichucher; Sergey E Dmitriev; Ivan V Smirnov; Olga G Shamborant; Dmitry S Balabashin; Lidia P Sashchenko; Alexander G Tonevitsky; Alain Friboulet; Alexander G Gabibov; Sergey M Deyev
Journal:  PLoS One       Date:  2011-06-06       Impact factor: 3.240

9.  Type 1 diabetes risk and autoantibody positivity in Sardinian migrants in the province of Pavia.

Authors:  Maria T Tenconi; Gabriele Devoti; Maria Rizzo; Federico Roncarolo; Andrea Bernasconi; Niccolò Lanati; Valeria Calcaterra; Marco Songini; Mattia Locatelli; Gian F Bottazzo
Journal:  N Am J Med Sci       Date:  2009-07

10.  Glutamic acid decarboxylase (anti-GAD) & tissue transglutaminase (anti-TTG) antibodies in patients with thyroid autoimmunity.

Authors:  R K Marwaha; M K Garg; N Tandon; Ratnesh Kanwar; A Narang; A Sastry; A Saberwal; Kuntal Bhadra
Journal:  Indian J Med Res       Date:  2013-01       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.